Venom and Neurology: From Molecular Mechanism to Clinical Medicine
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Animal Venoms".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 1023
Special Issue Editor
Interests: spider peptide toxins; voltage-gated sodium channels; voltage-gated calcium channels; peptide toxin; pharmacology; ion channels
Special Issue Information
Dear Colleagues,
Animal venoms represent a rich source of bioactive molecules that have evolved to precisely interact with specific neurological targets, such as ion channels and receptors. This intricate interplay makes venoms powerful tools for probing the fundamental mechanisms of neurological function and dysfunction. This Special Issue, "Venom and Neurology: From Molecular Mechanism to Clinical Medicine", aims to bridge the gap between basic toxin research and clinical applications. We invite contributions that explore the neuropharmacology of venom components, their mechanisms of action at a molecular and cellular level, and their potential as lead compounds for diagnosing and treating neurological disorders. Topics of interest include, but are not limited to, the use of neurotoxins to study channelopathies, the development of novel neurotherapeutics (e.g., analgesics, anticonvulsants) inspired by venom peptides, and the clinical management of neurotoxic envenomations. By bringing together research from these interconnected fields, this Special Issue seeks to highlight the immense potential of venoms in advancing neurological science and medicine.
Prof. Dr. Meichun Deng
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurotoxins
- ion channels
- neurological disorders
- venom peptides
- channelopathies
- therapeutic applications
- pain
- envenomation
- drug discovery
- neuroscience
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
